Maraviroc

Last Updated: 04/28/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 1372 publications

Virtual screening and molecular fingerprinting for in silico designing of potential CCR5 inhibitors targeting HIV therapy.

Virtual screening and molecular fingerprinting for in silico designing of potential CCR5 inhibitors targeting HIV therapy.

Journal: Journal of biomolecular structure & dynamics
Published: March 01, 2026

Toxoplasma effector GRA15-driven CCL5 secretion enhances brain parasite load through microvascular sequestration of phagocytes.

Toxoplasma effector GRA15-driven CCL5 secretion enhances brain parasite load through microvascular sequestration of phagocytes.

Journal: mBio
Published: January 13, 2026

Maraviroc attenuates orbital remodeling, inflammation, and lipid dysregulation in a murine model of thyroid eye disease associated with Graves' disease.

Maraviroc attenuates orbital remodeling, inflammation, and lipid dysregulation in a murine model of thyroid eye disease associated with Graves' disease.

Journal: Frontiers in endocrinology
Published: October 01, 2025

Astrocytic CCL5 orchestrates CCR5-positive neuronal necroptosis in subarachnoid hemorrhage.

Astrocytic CCL5 orchestrates CCR5-positive neuronal necroptosis in subarachnoid hemorrhage.

Journal: Journal of neuroinflammation
Published: September 28, 2025

CCR-CCL axes as key upstream influencers of pancreatic ductal adenocarcinoma: CCR2-CCL2, CCR5-CCL5, CCR4-CCL17/22, CCR6-CCL20, CCR7-CCL19/21.

CCR-CCL axes as key upstream influencers of pancreatic ductal adenocarcinoma: CCR2-CCL2, CCR5-CCL5, CCR4-CCL17/22, CCR6-CCL20, CCR7-CCL19/21.

Journal: Frontiers in immunology
Published: September 25, 2025

Effect of RANTES on Vascular Contractile and Relaxant Responses in Rat Carotid Arteries.

Effect of RANTES on Vascular Contractile and Relaxant Responses in Rat Carotid Arteries.

Journal: Biological & pharmaceutical bulletin
Published: September 24, 2025

A CD25-chemokine receptor complex initiates noncanonical IL-2 signaling.

A CD25-chemokine receptor complex initiates noncanonical IL-2 signaling.

Journal: The Journal of biological chemistry
Published: September 18, 2025

Impact of HAART therapy on cognitive function in patients with HIV: a systematic review of randomized control trial.

Impact of HAART therapy on cognitive function in patients with HIV: a systematic review of randomized control trial.

Journal: Annals of medicine and surgery (2012)
Published: September 17, 2025

Intensification with a CCR5 inhibitor at antiretroviral therapy initiation modulates interleukin-18 and inflammation-driven immune pathways in people with HIV.

Intensification with a CCR5 inhibitor at antiretroviral therapy initiation modulates interleukin-18 and inflammation-driven immune pathways in people with HIV.

Journal: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
Published: September 09, 2025

Antiretroviral Therapy Intensification With Dolutegravir and/or Maraviroc Did Not Affect HIV-1 Cell-Associated DNA, RNA, and 2--LTR Circles Over 12 Weeks.

Antiretroviral Therapy Intensification With Dolutegravir and/or Maraviroc Did Not Affect HIV-1 Cell-Associated DNA, RNA, and 2--LTR Circles Over 12 Weeks.

Journal: Open forum infectious diseases
Published: August 12, 2025

Targeting ORM1-CCR5 axis inhibits the aggressive phenotype of synovial fibroblasts and alleviates RA.

Targeting ORM1-CCR5 axis inhibits the aggressive phenotype of synovial fibroblasts and alleviates RA.

Journal: Open medicine (Warsaw, Poland)
Published: July 16, 2025

Single-cell transcriptomics unravels the early immune landscape of renal allograft rejection and nominates Ccl3-Ccr5 as a therapeutic target.

Single-cell transcriptomics unravels the early immune landscape of renal allograft rejection and nominates Ccl3-Ccr5 as a therapeutic target.

Journal: Frontiers in immunology
Published: July 10, 2025
Showing 1-12 of 1,372

Last Updated: 04/28/2026